Thermopylae Capital Inc.
TTSXV:THY.P0.08
CAD
0.00
(0.00%)
Thermopylae Capital Inc.
TSXV:THY.P
(TSX Venture Exchange)
Recent
price
0.08
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
CAD
•
in mil. unless spec.Working Capital
CAD
•
in mil. unless spec.Growth Rates
CAD
•
in mil. unless spec.Quarterly Revenue
CAD
•
in mil. unless spec.Quarterly Earnings Per Share
CAD
•
in mil. unless spec.Quarterly Dividends Per Share
CAD
•
in mil. unless spec.- Similar Companies
- Business
- Thermopylae Capital Inc. is a capital pool company that operates within the financial services and capital markets sectors, primarily engaged in identifying, evaluating, and negotiating the acquisition of operating businesses or assets to complete a Qualifying Transaction pursuant to Policy 2.4 of the TSX Venture Exchange. The company provides a corporate and financial vehicle for private commercial enterprises seeking a public listing on Canadian capital markets; structural evaluation and due diligence assessments for target asset acquisitions; capital allocation and treasury management services; and transaction structuring capabilities, including share exchange agreements, asset purchase transactions, amalgamations, and reverse takeovers across multiple industry verticals. Headquartered in Toronto, Ontario, Canada, Thermopylae Capital Inc. was incorporated in 2024 and focuses its evaluation activities on emerging growth opportunities in North America and international markets. In recent developments, the company completed its initial public offering on the TSX Venture Exchange in March 2026 under the ticker symbol THY.P, issuing 3,330,000 common shares to raise gross proceeds of 333,000 Canadian dollars following the acceptance of its amended and restated prospectus across Ontario, British Columbia, and Quebec. Additionally, the corporation underwent executive restructuring in July 2026 following the resignation of its President, Nicholas Aristotle Demos, with executive governance and acquisition evaluation activities continuing under the leadership of Chief Executive Officer Dr. Kenneth Matziorinis and Chief Financial Officer Véronique Laberge.